细胞外基质与血管成形术后再狭窄的关系
摘要
PTA后血管再狭窄既往研究集中于VSMCS的迁移、增殖,这一过程被认为是内膜增生和术后再狭窄的主要原因[1].
出处
《影像诊断与介入放射学》
2003年第3期182-186,共5页
Diagnostic Imaging & Interventional Radiology
参考文献26
-
1Batchelor WB, Robinson R, Strauss BH, et al. The extracellular matrix in balloon arterial injury: a novel target for restenosis prevention, Prog Cardiovasc Dis, 1998, 41:35 -49.
-
2Hamon M, Bauters C, Mcfadden EP, Wernert N, et al. Restenosis after coronary angioplasty. Eur Heart J, 1995, 16 Suppl I: 33-48.
-
3Assoian RK, Marcantonio EE, Olacn BC, et al. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J Clin Invest, 1996, 98:2436 - 2439.
-
4Ferns GA, Stewart - Lee AL, Anggard EE. et al. Arterial response to mechanical injury: balloon catheter de - endothelialization. Atherosclerosis, 1992, 92:89 - 104. Review.
-
5Moiseeva EP, Javed Q, Spring EL, et al. Galectin 1 is involved in vascular smooth muscle cell proliferation. Cardiovasc Res, 2000,45:493 - 502.
-
6Madri JA, Bell L, Marx M. et al. Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de - endothelialization and repair. J Cell Biochem, 1991:123 - 30. Review.
-
7Engvall E, Earwicker D, Haaparanta T, et al. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul, 1990, 1:731 -40.
-
8Okada H, Nordt T, Lundgren CH, et al. Human aortic vascular smooth muscle cells digest extracellular matrix by elaboration of plasminogen activators: Implications for atherogenesis. J Thromb Thrombolysis, 1995, 2:107 - 112.
-
9Chen YH, Chen YL, Lin SJ, et al. Electron microscopic studies of phenotypic modulation of smooth muscle cells in coronary arteries of patients with unstable angina pectoris and postangioplasty restenosis. Circulation, 1997, 95:1169 - 1175.
-
10Simmons ML, Chavkin C. Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol. 1996, 39:145 -96. Review.
-
1尹航.血管成形术后再狭窄发生机制的研究现状[J].江苏医药,1997,23(4):257-258.
-
2葛夕洪,贺能树.细胞外基质与血管成形术后再狭窄[J].国外医学（临床放射学分册）,2004,27(5):327-330.
-
3吴永全.基质金属蛋白酶与血管成形术后再狭窄[J].中国介入心脏病学杂志,1997,5(2):92-93. 被引量：2
-
4郗永安,汪丽蕙.血管成形术后再狭窄实验模型[J].中国介入心脏病学杂志,1995,3(4):189-191. 被引量：16
-
5王俊杰,陈明.血管腔内放射治疗防止血管成形术后再狭窄的研究进展[J].中国煤炭工业医学杂志,1998,1(3):197-200.
-
6黄贤生,王东明.血管成形术后再狭窄的研究进展和钙通道阻滞剂的预防作用[J].汕头大学医学院学报,2003,16(1):54-56. 被引量：1
-
7朱光辉.Budd—Chiari syndrome的介入治疗[J].中外医用放射技术,1999(3):69-70.
-
8王松,贺能树.生长因子与血管成形术后再狭窄[J].介入放射学杂志,1998,7(3):179-187.
-
9张茜.凝血酶与血管损伤后的再狭窄[J].中国循环杂志,1997,12(4):313-315.
-
10杨杰.冠心病介入治疗术后再狭窄及对策[J].河北医学,1999,5(2):73-74. 被引量：1
